Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QGLY - Funny Name Great Product. -- Ignore unavailable to you. Want to Upgrade?

To: George Eby who wrote (8882)	5/18/1999 8:58:00 AM
From: Ironyman	Read Replies (1) \| Respond to of 8960

When they lost the Nasal Spray case, that was it. ...Case precedence will allow a few more players in the door. It doesn't matter that they have a better product, the fact that each player will take a couple of points will eliminate any profits to shareholders.

To: George Eby who wrote (8882)	5/19/1999 7:53:00 PM
From: VIPER85730	Read Replies (1) \| Respond to of 8960

George, >Why would Quigley buy back stock when I have wrote him a very clear letter informing him that his predictions for growth were wrong because there will be major, old time, cough cold players entering the market this year and more the following year using really effective zinc acetate lozenges supported by extremely strong clinical trial reports? Didn't he put that in some kind of SEC report? If not, shouldn't he? I guess he still don't trust that Eby fellow.< Who knows? Maybe he knows something that you don't. After all, he does own the place! One thing is for sure, like anyone else, Guy wouldn't be buying the stock unless he expected it to pay off down the road. One reason that I continue to watch it comfortably on the sidelines. VIPER-------< P.S. By the way, by "MAJOR, OLD TIME, COUGH COLD PLAYERS" do you mean LARGER than Warner Lambert? Gimme a break George.